This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 7 from Patent US 20120302729
General Information
DRACP ID DRACP01415
Peptide Name Sequence 7 from Patent US 20120302729
Sequence KAMQDAEVSKSDIGEVILVGGMTRMPKVQQTVQDLFGRAPSKAVNPDEAV
Sequence Length 50
UniProt ID Not available
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C229H383N65O75S3
Absent amino acids CHWY
Common amino acids V
Mass 621734
Pl 4.8
Basic residues 6
Acidic residues 7
Hydrophobic residues 17
Net charge -1
Boman Index -8069
Hydrophobicity -26.6
Aliphatic Index 81.8
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 10
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2012/0302729 A1
Patent Title Anticancer anti-mortalin peptide antibody.
Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: EP, US, WO, JP; Legal Status: Inactive; Application No: 201013514755; Filed:Dec 9, 2010; Published: Nov 29, 2012; Earliest Priority: Dec 10, 2009; Granted: Nov 19, 2013
Other Published ID EP2511371A1 EP2511371A4
This work is licensed under a Creative Commons Attribution 4.0 International License.